Regenerative Medicine in Medical – Thematic Research
All the vital news, analysis, and commentary curated by our industry experts.
Regenerative Medicine in Medical Market Thematic Overview
Regenerative medicine is an innovative field of medicine that holds the potential to fully cure diseases, eliminate cancer, and heal old and damaged tissue. Regenerative medicine is relevant to the orthopedic, cardiovascular, neurological, wound care, cancer, and pharmaceutical markets. The three main branches of regenerative medicine are gene therapy, cell therapy, and tissue repair. Currently, available gene therapies focus on curing rare diseases, but research is gaining traction in both prevalent and polygenic diseases. Market players in regenerative medicine range from large dominant corporations to small innovative start-ups. While the big-name corporations leverage their presence in relevant markets around the world, the start-ups continually develop novel technologies and expand regenerative medicine capabilities.
The Regenerative Medicine in Medical thematic intelligence report briefs about the types of regenerative medicine. It provides an overview of the current landscape, including healthcare, technology, regulatory, macroeconomic trends, and key players. The primary focus of this report is on regenerative medicine therapies that act as medical devices and are not strictly drug-related.
|Market Size (2021)||$2.2 billion|
|Key Trends||Technology, Macroeconomic, and Regulatory|
|Value Chain||Gene Therapies, Cell Therapies and Tissue Repair|
|Leading companies in Regenerative Medicine||Astellas Pharma, Bayer, Bristol Myers Squibb, Novartis and SanBio|
The main trends shaping the Regenerative Medicine space in the medical industry are classified into three categories: technology trends, macroeconomic trends, and regulatory trends.
Technology trends – The report focuses on key technology trends impacting the regenerative medicine theme, which include gene therapy, cell therapy, and tissue repair.
Macroeconomic trends – The report analyses macroeconomic trends impacting the regenerative medicine theme, which include funding and clinical trials.
Regulatory trends – The report highlights the key regulatory trends issued by countries such as the US, Europe, Japan, China, and South Korea impacting the regenerative medicine theme.
For more insights on key trends impacting regenerative medicine theme in medical industry, download a free report sample
Regenerative Medicine in Medical – Industry Analysis
Based on the tracked sales of approved regenerative medicines, GlobalData estimates that the market size in 2021 was $2.2 billion and is expected to grow at a compound annual growth rate (CAGR) of more than 40%. Regenerative medicine will provide therapeutic options for previously untreatable diseases, but each segment faces unique challenges. For instance, the gene therapy market has a couple of significant product approvals in the rare disease space. Still, the high cost of these therapies is currently hindering their widespread adoption. Cell therapy bridges an important gap in oncology therapies but requires training of the patient’s own cells, which may respond differently on a case-by-case basis. Hence, it is currently not a generalizable therapy.
The Regenerative Medicine in Medical report analyses the market size and growth forecasts of various segments of regenerative therapies. It also identifies key players who can leverage their presence in relevant markets worldwide and small innovative start-ups that continually develop novel technology and expand regenerative medicine capabilities.
The Regenerative Medicine in Medical market analysis also covers:
- Mergers and acquisitions
- Patent trends
- Social media trends
For more regenerative medicine in medical industry analysis, download a free report sample
Regenerative Medicine in Medical - Value Chain Analysis
GlobalData’s regenerative medicine value chain in medical industry categorized into three major segments based on the form of the therapeutic agent used. They are gene therapies, cell therapies and tissue repair.
Gene therapies offer a unique opportunity to cure patients; however, there are many technical challenges in developing gene therapies, including the host’s gene sequences, gene editing facilitators, and gene vectors. Pharmaceutical companies such as Novartis and Bluebird bio are working out payment plan details to increase patient access to these therapies. For instance, Novartis has seen success with Zolgensma globally and recently received approvals to expand its market to Australia and South Korea.
Regenerative medicine Value Chain in Medical
For more insights on the Big Data value chain in pharma, download a free report sample
Leading Companies in the Regenerative Medicine Theme
Some of the leading vendors making their mark within the regenerative medicine theme:
- Astellas Pharma
- Bristol Myers Squibb
To know more about leading companies associated with the regenerative medicine theme in the medical industry, download a free report sample
This report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats. Inside, we predict how each theme will evolve and identify the leading and disrupting companies.
The report covers the Regenerative Medicine theme.
Table of Contents
Our Thematic Research Methodology
Frequently asked questions
What was the market size of the Regenerative Medicine in Medical sector in 2021?
The Regenerative Medicine in Medical market was valued at $2.2 billion in 2021.
What are the key technology trends shaping Regenerative Medicine in Medical sector?
The key technology trends impacting the regenerative medicine theme include gene therapy, cell therapy and tissue repair.
What are the key macroeconomic trends shaping Regenerative Medicine in Medical industry?
The macroeconomic trends impacting the regenerative medicine theme which include funding and clinical trials.
What are the components of value chain of Regenerative Medicine in Medical industry?
GlobalData’s regenerative medicine value chain in medical industry is split into three segments: gene therapy, cell therapy and tissue repair.
Which are the leading vendors of Regenerative Medicine theme in Medical industry?
Some of the vendors making their mark within Regenerative Medicine in Medical industry are Astellas Pharma, Bayer, Bristol Myers Squibb, Novartis and SanBio among others.
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.